Not Applicable.
The present invention relates in general to ventricular support pumps and controls, and, more specifically, to a ventricular assist device for reducing load applied to a weakened ventricle during the systolic phase.
Many types of circulatory assist devices are available for either short term or long term support for patients having cardiovascular disease. For example, a heart pump system known as a left ventricular assist device (LVAD) can provide long term patient support with an implantable pump associated with an externally-worn pump control unit and batteries. The LVAD improves circulation throughout the body by assisting the left side of the heart in pumping blood. One such system is the DuraHeart® LVAS system made by Terumo Heart. Inc., of Ann Arbor, Mich. The DuraHeart® system employs a centrifugal pump with a magnetically levitated impeller to pump blood from the left ventricle to the aorta. The impeller can act as a rotor of an electric motor in which a rotating magnetic field from a multiphase stator couples with the impeller and is rotated at a speed appropriate to obtain the desired blood flow through the pump.
A typical cardiac assist system includes a pumping unit, drive electronics, microprocessor control unit, and an energy source such as rechargeable batteries and/or an AC power conditioning circuit. The system is implanted during a surgical procedure in which a centrifugal pump is placed in the patient's chest. An inflow conduit is pierced into the left ventricle to supply blood to the pump. One end of an outflow conduit is mechanically fitted to the pump outlet and the other end is surgically attached to the patient's aorta by anastomosis. A percutaneous cable connects to the pump, exits the patient through an incision, and connects to the external control unit. An LVAD system may be used with or without a pacemaker.
A control system for varying pump speed to achieve a target blood flow based on physiologic conditions is shown in U.S. Pat. No. 7,160,243, issued Jan. 9, 2007, which is incorporated herein by reference in its entirety. A target blood flow rate may be established based on the patient's heart rate so that the physiologic demand is met. In one type of conventional control unit, a constant speed setpoint has been determined for the pump motor to achieve the target flow based on demand. In this type of system, the pump speed is substantially constant within an individual cardiac cycle.
Pulsatile pumping systems are also known wherein the pump speed is varied within the cardiac cycle to more closely mimic natural heart action. In one example, U.S. Pat. No. 8,096,935 to Sutton et al oscillates the speed of the pump to produce a pulsed pressure. The speed is oscillated synchronously with the natural cardiac cycle such that a pump speed is increased during systole (the time of highest flow) and decreased during diastole (the time of lowest flow).
Whether operated at a constant speed or in a pulsatile manner, it is known that when desiring to obtain a maximum unloading of a weakened ventricle the average pump speed should be increased as much as possible (so that the pump flow is increased to the point where it captures almost the entire cardiac output). Due to flow inertia, however, the pump flow lags the ventricular pressure increase occurring at the beginning of systole. Therefore, the ventricle contraction still remains isometric at the beginning of systole (i.e., the pressure inside the ventricle resists its contraction). Furthermore, an increased average pump speed increases the risk of ventricular suction, particularly at the end of systole when the ventricle could be nearly empty.
In order to make ventricular contraction easier, the pump speed is increased before the systolic phase of cardiac cycle. As a result, the intra-ventricular pressure is reduced prior to ventricular contraction allowing a weak ventricle to contract with reduced resistance. In order to prevent ventricular suction, the pump speed is reduced to before the end of systole when the ventricle is nearly empty.
In one aspect of the invention, a blood pump system is provided for implanting in a patient for ventricular support. A pumping chamber has an inlet for receiving blood from a ventricle of the patient. An impeller is received in the pumping chamber. A motor is coupled to the impeller for driving rotation of the impeller. A motor controller is provided for tracking systolic and diastolic phases of a cardiac cycle of the patient and supplying a variable voltage signal to the motor in a variable speed mode to produce a variable impeller speed linked to the cardiac cycle. The impeller speed comprises a ramping up to an elevated speed during the diastolic phase in order to reduce a load on the ventricle at the beginning of the systolic phase. In some embodiments, the impeller speed also comprises a ramping down to a reduced speed during the systolic phase to avoid collapse of the ventricle.
The variable speed mode may be comprised of a constant current mode or may be comprised of a speed control for matching impeller speed to a target speed in which the target speed ramps up to the elevated speed during the diastolic phase and ramps down to a reduced speed during the systolic phase to avoid collapse of the ventricle.
The motor controller may be configurable to provide the variable voltage signal to the motor in either the above variable speed mode or a constant speed mode. The constant speed mode maintains a substantially constant speed of the impeller over each respective cardiac cycle. A selection between the variable speed mode and the constant speed mode is determined according to a physiologic capability of the patient. This allows for selective therapy during LVAD support. For example, immediately following the implantation when the left ventricle is weak, the pump is set to operate in the constant current mode thereby providing a greater level of ventricle unloading. With the patient's recovery, the pump may be set to operate in the constant speed mode, promoting higher flow pulsatility and a more natural physiologic response to the patient's activities.
Referring to
To help avoid collapse of the ventricle toward the end of systole or during diastole, impeller speed 52 preferably ramps down at segment 57 from elevated speed 53 to reduced speed 54. Segment 57 begins during the systolic phase of the cardiac cycle (i.e., before the beginning of diastole 51). For example, current curve 49 starts to ramp down at a time 58 which precedes start of diastole 51 by a time t2. Preferably, time 58 may be at a moment between about 50% to about 90% into the systolic phase. Thus, denoting the length of the systolic phase as ts, the ratio t1/ts is preferably between 0.1 and 0.5.
As shown in
A pump system of the present invention is shown in greater detail in
An average target speed or rpm for operating the pump is provided by a physiological monitor 68 to FOC block 66. The average rpm may be set by a medical caregiver or may be determined according to an algorithm based on various patient parameters such heart beat. Monitor 68 may also generate a status signal for identifying whether the ventricle is in the initial, highly weakened state or whether a predetermined recovery has been obtained in the strength of the ventricle. The average rpm and the status signal are provided to a speed command calculator 70. The status signal can be used to determine whether or not the variable speed control of the invention should be used to unload the ventricle. The status signal can alternatively be externally provided to calculator 70 (e.g., by a physician via an HMI).
Command calculator 70 is coupled to a cycle tracking block 71 which maintains timing for a cardiac cycle reference. A current signal (e.g., currents ia, ib, and ic) can be used in order to detect the cardiac cycle from the instantaneous blood flow, for example. More specifically, the controller may identify the heart rate by measuring time between current peaks in the speed control mode. Then the speed decrease can start at a calculated time after the occurrence of a current peak. The speed increase can start at a calculated time after the current minimum value is to detected. This calculated time typically depends on the heart rate.
Alternatively, cycle tracking block 71 can be coupled to a pacemaker 72 in the event that the patient is using such a device. Conventional pacemakers have been constructed to continuously generate radio signals that contain information about pulse timing and other data. These sine-wave modulated signals can be received by a special receiver (not shown), where the signals are demodulated, digitized (if necessary), and transferred to cycle tracking block 71. Besides being located near the implanted pacemaker and connected by a cable or wirelessly to the controller (e.g., via BlueTooth), a receiver could be integrated with the controller or the pumping unit.
Based on the reference cycle timing from block 71, command calculator 70 determines an instantaneous speed (or magnitude of the current vector) to be used by FOC block 66. FOC block 66 generates commanded voltage output values va, vb, and vc which are input to PWM block 63. The va, vb, and vc commands may also be coupled to observer 67 for use in detecting speed and position (not shown). Thus, the speed is controlled to follow the curves shown in
In one embodiment, the timing of the speed increases and decreases are determined as follows. At a constant pacing rate (i.e., constant beat rate), the time for starting the speed acceleration (e.g., at time 56 in
tacc(n+1)=tp(n)+60/N−t1.
where tp(n) is the time of occurrence of a pacemaker pulse time signaling the start of the current cardiac cycle; N is the heart (pulse) rate in beat/min set by a pacemaker; and tacc(n+1) is the time to increase the pump speed for the next cardiac cycle. Similarly, the time to start deceleration (e.g., at a time 58 in
tdecel(n+1)=ta(n+1)+ts
where ts is the duration of systole. Systole typically lasts 30% to 50% of the cardiac cycle 60/N, and within a certain heart rate range it is fairly independent of the heart rate N. For example, for a heart rate N between 60-120 beats/min, ts is between 0.30 seconds and 0.25 seconds.
In an alternative embodiment, command calculator 70 and FOC block 66 are configured to operate the motor in a constant current mode (i.e., a constant torque mode). In this mode, the speed changes inversely with the pump load (i.e., the flow rate). Thus, an average speed is determined by the physiological monitor. The motor controller adjusts the current to obtain the desired average speed and to keep the current substantially constant. By keeping a constant current in the face of a load which varies within the cardiac cycle, the impeller speed automatically changes.
In the current control mode, the pump flow increases (load increases) in the beginning of systole (at 78) and the speed curve 81 drops to a reduced speed 83. At the end of systole, the flow drops (at 80) and speed increases to an elevated speed 82. Thus, the speed increases and stays relatively high during diastole to help unload the ventricle by pumping out blood at the time it fills the ventricle. This is a natural behavior of the pump in the current control mode.
Either the variable speed control mode using a variable target speed or using the constant current approach of the invention can be combined with the conventional constant speed mode in order to adapt pump performance to the strength level of the patient's ventricle. In particular, the selection between the variable speed mode and the constant speed mode can be determined according to a physiologic capability of the patient. For example, the pump is set to operate in the constant current mode immediately following the implantation when the left ventricle is weak, thereby providing a greater level of ventricle unloading. With the patient's recovery, the pump may be set to operate in the constant speed mode, promoting higher flow pulsatility and a more natural physiologic response to the patient's activities.
This application is a continuation of U.S. application Ser. No. 15/640,001, filed on Jun. 30, 2017, which is a continuation of U.S. application Ser. No. 13/873,551, filed on Apr. 30, 2013, now U.S. Pat. No. 9,713,663, the disclosures of which are incorporated herein by reference in its entirety, for all purposes, as if fully set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
1093868 | Leighty | Apr 1914 | A |
2684035 | Kemp | Jul 1954 | A |
3510229 | Smith | May 1970 | A |
3932069 | Giardini et al. | Jan 1976 | A |
3960468 | Boorse et al. | Jun 1976 | A |
4149535 | Voider | Apr 1979 | A |
4382199 | Isaacson | May 1983 | A |
4392836 | Sugawara | Jun 1983 | A |
4507048 | Belenger et al. | Mar 1985 | A |
4540402 | Aigner | Sep 1985 | A |
4549860 | Yakich | Oct 1985 | A |
4686982 | Nash | Aug 1987 | A |
4688998 | Olsen et al. | Aug 1987 | A |
4753221 | Kensey et al. | Jun 1988 | A |
4769006 | Papatonakos | Sep 1988 | A |
4790843 | Carpentier et al. | Dec 1988 | A |
4806080 | Mizobuchi et al. | Feb 1989 | A |
4817586 | Wampler | Apr 1989 | A |
4846152 | Wampler et al. | Jul 1989 | A |
4888011 | Kung et al. | Dec 1989 | A |
4895557 | Moise et al. | Jan 1990 | A |
4900227 | Troup Iin | Feb 1990 | A |
4902272 | Milder et al. | Feb 1990 | A |
4906229 | Wampler | Mar 1990 | A |
4908012 | Moise et al. | Mar 1990 | A |
4919647 | Nash | Apr 1990 | A |
4930997 | Bennett | Jun 1990 | A |
4944722 | Carriker et al. | Jul 1990 | A |
4957504 | Chardack | Sep 1990 | A |
4969865 | Hwang et al. | Nov 1990 | A |
4985014 | Orejola | Jan 1991 | A |
4995857 | Arnold | Feb 1991 | A |
5092844 | Schwartz et al. | Mar 1992 | A |
5092879 | Jarvik | Mar 1992 | A |
5106263 | Irie | Apr 1992 | A |
5106273 | Lemarquand et al. | Apr 1992 | A |
5106372 | Ranford | Apr 1992 | A |
5112202 | Ozaki et al. | May 1992 | A |
5129883 | Black | Jul 1992 | A |
5145333 | Smith | Sep 1992 | A |
5147186 | Buckholtz | Sep 1992 | A |
5112349 | Summers et al. | Dec 1992 | A |
5190528 | Fonger et al. | Feb 1993 | A |
5201679 | Velte et al. | Apr 1993 | A |
5211546 | Isaacson et al. | May 1993 | A |
5275580 | Yamazaki | Jan 1994 | A |
5290227 | Pasque | Jan 1994 | A |
5360445 | Goldowsky | Jan 1994 | A |
5290236 | Mathewson | Mar 1994 | A |
5306295 | Kolff et al. | Apr 1994 | A |
5312341 | Turi | May 1994 | A |
5332374 | Kricker et al. | Jul 1994 | A |
5346458 | Afield | Sep 1994 | A |
5350283 | Nakazeki et al. | Sep 1994 | A |
5354331 | Schachar | Nov 1994 | A |
5370509 | Golding et al. | Dec 1994 | A |
5385581 | Bramm et al. | Jan 1995 | A |
5405383 | Barr | Nov 1995 | A |
5449342 | Hirose et al. | Dec 1995 | A |
5478222 | Heidelberg et al. | Dec 1995 | A |
5504978 | Meyer, III | Apr 1996 | A |
5507629 | Jarvik | Apr 1996 | A |
5533957 | Aldea | Sep 1996 | A |
5569111 | Cho et al. | Oct 1996 | A |
5575630 | Nakazawa et al. | Nov 1996 | A |
5595762 | Derrieu et al. | Jan 1997 | A |
5643226 | Cosgrove et al. | Jan 1997 | A |
5611679 | Ghosh et al. | Mar 1997 | A |
5613935 | Jarvik | Mar 1997 | A |
5678306 | Bozeman, Jr. et al. | Oct 1997 | A |
5692882 | Bozeman, Jr. et al. | Dec 1997 | A |
5695471 | Wampler | Dec 1997 | A |
5725357 | Nakazeki et al. | Mar 1998 | A |
5738649 | Macoviak | Apr 1998 | A |
5746575 | Westphal et al. | May 1998 | A |
5746709 | Rom et al. | May 1998 | A |
5755784 | Jarvik | May 1998 | A |
5776111 | Tesio | Jul 1998 | A |
5795074 | Rahman et al. | Aug 1998 | A |
5800559 | Higham et al. | Sep 1998 | A |
5807311 | Palestrant | Sep 1998 | A |
5814011 | Corace | Sep 1998 | A |
5824069 | Lemole | Oct 1998 | A |
5749855 | Reitan | Dec 1998 | A |
5851174 | Jarvik et al. | Dec 1998 | A |
5853394 | Tolkoff et al. | Dec 1998 | A |
5890883 | Golding et al. | Apr 1999 | A |
5924848 | Izraelev | Jul 1999 | A |
5924975 | Goldowsky | Jul 1999 | A |
5928131 | Prem | Jul 1999 | A |
5938412 | Israelev | Aug 1999 | A |
5941813 | Sievers et al. | Aug 1999 | A |
5868702 | Stevens et al. | Sep 1999 | A |
5868703 | Bertolero et al. | Sep 1999 | A |
5947703 | Nojiri et al. | Sep 1999 | A |
5951263 | Taylor et al. | Sep 1999 | A |
5964694 | Siess et al. | Dec 1999 | A |
6004269 | Crowley et al. | Dec 1999 | A |
6007479 | Rottenberg et al. | Dec 1999 | A |
6030188 | Nojiri et al. | Feb 2000 | A |
6042347 | Scholl et al. | Mar 2000 | A |
6053705 | Schob et al. | Apr 2000 | A |
6066086 | Antaki et al. | May 2000 | A |
6071093 | Hart | Jun 2000 | A |
6074180 | Khanwilkar et al. | Jun 2000 | A |
6080133 | Wampler | Jun 2000 | A |
6082900 | Takeuchi et al. | Jul 2000 | A |
6100618 | Schoeb et al. | Aug 2000 | A |
6058593 | Siess | Sep 2000 | A |
6123659 | leBlanc et al. | Sep 2000 | A |
6123726 | Mori et al. | Sep 2000 | A |
6139487 | Siess | Oct 2000 | A |
6086527 | Talpade | Nov 2000 | A |
6142752 | Akamatsu et al. | Nov 2000 | A |
6143025 | Stobie et al. | Nov 2000 | A |
6146325 | Lewis et al. | Nov 2000 | A |
6149683 | Lancisi et al. | Nov 2000 | A |
6158984 | Cao et al. | Dec 2000 | A |
6171078 | Schob | Jan 2001 | B1 |
6176822 | Nix et al. | Jan 2001 | B1 |
6176848 | Rau et al. | Jan 2001 | B1 |
6190304 | Downey et al. | Feb 2001 | B1 |
6206659 | Izraelev | Mar 2001 | B1 |
6254359 | Aber | Mar 2001 | B1 |
6227797 | Watterson et al. | May 2001 | B1 |
6227820 | Jarvik | May 2001 | B1 |
6234772 | Wampler et al. | May 2001 | B1 |
6234998 | Wampler | May 2001 | B1 |
6247892 | Kazatchkov et al. | Jun 2001 | B1 |
6264635 | Wampler et al. | Jul 2001 | B1 |
6293901 | Prem | Sep 2001 | B1 |
6295877 | Aboul-Hosn et al. | Oct 2001 | B1 |
6319231 | Andrulitis | Nov 2001 | B1 |
6245007 | Bedingham et al. | Dec 2001 | B1 |
6458163 | Slemker et al. | Jan 2002 | B1 |
6351048 | Schob et al. | Feb 2002 | B1 |
6375607 | Prem | Apr 2002 | B1 |
6422990 | Prem | Jul 2002 | B1 |
6425007 | Messinger | Jul 2002 | B1 |
6428464 | Bolling | Aug 2002 | B1 |
6439845 | Veres | Aug 2002 | B1 |
6447266 | Antaki et al. | Sep 2002 | B2 |
6447441 | Yu et al. | Sep 2002 | B1 |
6508777 | Macoviak et al. | Jan 2003 | B1 |
6508787 | Erbel et al. | Jan 2003 | B2 |
6532964 | Aboul-Hosn et al. | Mar 2003 | B2 |
6533716 | Schmitz-Rode et al. | Mar 2003 | B1 |
6544216 | Sammler et al. | Apr 2003 | B1 |
6547519 | deBlanc et al. | Apr 2003 | B2 |
6547530 | Ozaki et al. | Apr 2003 | B2 |
6595762 | Khanwilkar et al. | Jul 2003 | B2 |
6609883 | Woodard et al. | Aug 2003 | B2 |
6623420 | Reich et al. | Sep 2003 | B2 |
6641558 | Aboul-Hosn et al. | Nov 2003 | B1 |
6688861 | Wampler | Feb 2004 | B2 |
6692318 | McBride | Feb 2004 | B2 |
6698097 | Miura et al. | Mar 2004 | B1 |
6709418 | Aboul-Hosn et al. | Mar 2004 | B1 |
6716189 | Jarvik et al. | Apr 2004 | B1 |
6776578 | Belady | Aug 2004 | B2 |
6790171 | Griindeman et al. | Sep 2004 | B1 |
6794789 | Siess et al. | Sep 2004 | B2 |
6808371 | Niwatsukino et al. | Oct 2004 | B2 |
6817836 | Nose et al. | Nov 2004 | B2 |
6860713 | Hoover | Jan 2005 | B2 |
6935344 | Aboul-Hosn et al. | Aug 2005 | B1 |
6926662 | Aboul-Hosn et al. | Sep 2005 | B1 |
6942672 | Heilman et al. | Sep 2005 | B2 |
6949066 | Beamson et al. | Sep 2005 | B2 |
6974436 | Aboul-Hosn et al. | Dec 2005 | B1 |
6991595 | Burke et al. | Jan 2006 | B2 |
7010954 | Siess et al. | Mar 2006 | B2 |
7011620 | Siess | Mar 2006 | B1 |
7048681 | Tsubouchi et al. | May 2006 | B2 |
7112903 | Schob | Sep 2006 | B1 |
7128538 | Tsubouchi et al. | Oct 2006 | B2 |
7027875 | Siess et al. | Nov 2006 | B2 |
7156802 | Woodard et al. | Jan 2007 | B2 |
7160243 | Medvedev | Jan 2007 | B2 |
7175588 | Morello | Feb 2007 | B2 |
7172551 | Leasure | Jun 2007 | B2 |
7241257 | Ainsworth et al. | Oct 2007 | B1 |
7331921 | Viole et al. | Feb 2008 | B2 |
7335192 | Keren et al. | Feb 2008 | B2 |
7431688 | Wampler et al. | Oct 2008 | B2 |
7329236 | Kesten et al. | Dec 2008 | B2 |
7467930 | Ozaki et al. | Dec 2008 | B2 |
7470246 | Mori et al. | Dec 2008 | B2 |
7491163 | Viole et al. | Feb 2009 | B2 |
7575423 | Wampler | Aug 2009 | B2 |
7645225 | Medvedev et al. | Jan 2010 | B2 |
7699586 | LaRose et al. | Apr 2010 | B2 |
7748964 | Yaegashi et al. | Jul 2010 | B2 |
7731675 | Aboul-Hosn et al. | Aug 2010 | B2 |
7802966 | Wampler et al. | Sep 2010 | B2 |
7841976 | McBride et al. | Nov 2010 | B2 |
7888242 | Tanaka et al. | Feb 2011 | B2 |
7934909 | Nuesser et al. | May 2011 | B2 |
7976271 | LaRose et al. | Jul 2011 | B2 |
7997854 | LaRose et al. | Aug 2011 | B2 |
8007254 | LaRose et al. | Aug 2011 | B2 |
8096935 | Sutton et al. | Jan 2012 | B2 |
8123669 | Siess et al. | Feb 2012 | B2 |
8226373 | Yaehashi | Jul 2012 | B2 |
8282359 | Ayre et al. | Oct 2012 | B2 |
8283829 | Yamamoto et al. | Oct 2012 | B2 |
8366381 | Woodard et al. | Feb 2013 | B2 |
8403823 | Yu et al. | Mar 2013 | B2 |
8512012 | Mustafa et al. | Aug 2013 | B2 |
8652024 | Yanai et al. | Feb 2014 | B1 |
9713663 | Medvedev et al. | Jul 2017 | B2 |
10456513 | Medvedev et al. | Oct 2019 | B2 |
20020058994 | Hill et al. | May 2002 | A1 |
20020095210 | Finnegan et al. | Jul 2002 | A1 |
20030023302 | Moe et al. | Jan 2003 | A1 |
20030045772 | Reich et al. | Mar 2003 | A1 |
20030199727 | Burke et al. | Oct 2003 | A1 |
20040007515 | Geyer | Jan 2004 | A1 |
20040024285 | Muckter | Feb 2004 | A1 |
20040030381 | Shu | Feb 2004 | A1 |
20040210305 | Shu et al. | Oct 2004 | A1 |
20050089422 | Ozaki et al. | Apr 2005 | A1 |
20050131271 | Benkowski et al. | Jun 2005 | A1 |
20050287022 | Yaehashi et al. | Dec 2005 | A1 |
20060024182 | Akdis et al. | Feb 2006 | A1 |
20060055274 | Kim | Mar 2006 | A1 |
20070078293 | Shambaugh, Jr. | Apr 2007 | A1 |
20070134993 | Tamez et al. | Jun 2007 | A1 |
20070208210 | Gelfand et al. | Sep 2007 | A1 |
20070213690 | Phillips et al. | Sep 2007 | A1 |
20070231135 | Wampler et al. | Oct 2007 | A1 |
20070297923 | Tada | Dec 2007 | A1 |
20080021394 | La Rose et al. | Jan 2008 | A1 |
20080030895 | Obara et al. | Feb 2008 | A1 |
20080124231 | Yaegashi | May 2008 | A1 |
20090060743 | McBride et al. | Mar 2009 | A1 |
20090074336 | Engesser et al. | Mar 2009 | A1 |
20090171136 | Shambaugh, Jr. | Jul 2009 | A1 |
20100222634 | Poirier | Sep 2010 | A1 |
20100256440 | Maher et al. | Oct 2010 | A1 |
20110112354 | Nishimura et al. | May 2011 | A1 |
20110118766 | Reichenbach et al. | May 2011 | A1 |
20110118829 | Hoarau et al. | May 2011 | A1 |
20110129373 | Mori | Jun 2011 | A1 |
20110243759 | Ozaki et al. | Oct 2011 | A1 |
20110298304 | Cotter | Dec 2011 | A1 |
20110318203 | Ozaki et al. | Dec 2011 | A1 |
20120003108 | Ozaki et al. | Jan 2012 | A1 |
20120016178 | Woodard et al. | Jan 2012 | A1 |
20120022645 | Burke | Jan 2012 | A1 |
20120035411 | LaRose et al. | Feb 2012 | A1 |
20120078030 | Bourque | Mar 2012 | A1 |
20120130152 | Ozaki et al. | May 2012 | A1 |
20120243759 | Fujisawa | Sep 2012 | A1 |
20120308363 | Ozaki et al. | Dec 2012 | A1 |
20130121821 | Ozaki et al. | May 2013 | A1 |
20130170970 | Ozaki et al. | Jul 2013 | A1 |
20130178694 | Jeffery et al. | Jul 2013 | A1 |
20130243623 | Okawa et al. | Sep 2013 | A1 |
20140030122 | Ozaki et al. | Jan 2014 | A1 |
20140323796 | Medvedev et al. | Oct 2014 | A1 |
20150017030 | Ozaki | Jan 2015 | A1 |
Number | Date | Country |
---|---|---|
102239334 | Nov 2011 | CN |
102341600 | Feb 2012 | CN |
1113117 | Jul 2001 | EP |
1495773 | Jan 2005 | EP |
2298375 | Mar 2011 | EP |
2372160 | Oct 2011 | EP |
2405140 | Jan 2012 | EP |
2461465 | Jun 2012 | EP |
3013385 | May 2016 | EP |
58-009535 | Jan 1983 | JP |
61-293146 | Dec 1986 | JP |
04-091396 | Mar 1992 | JP |
H04-148094 | May 1992 | JP |
05-021197 | Mar 1993 | JP |
H06-014538 | Feb 1994 | JP |
06-053790 | Jul 1994 | JP |
2006-070476 | Sep 1994 | JP |
2006-245455 | Sep 1994 | JP |
07-014220 | Mar 1995 | JP |
H07-042869 | Aug 1995 | JP |
H07-509156 | Oct 1995 | JP |
09-122228 | May 1997 | JP |
H10-331841 | Dec 1998 | JP |
11-244377 | Sep 1999 | JP |
2001-309628 | Nov 2001 | JP |
2003-135592 | May 2003 | JP |
2004-166401 | Jun 2004 | JP |
2004-209240 | Jul 2004 | JP |
2004-332566 | Nov 2004 | JP |
2004-346925 | Dec 2004 | JP |
2005-94955 | Apr 2005 | JP |
2005-127222 | May 2005 | JP |
2005-245138 | Sep 2005 | JP |
2005-270345 | Oct 2005 | JP |
2005-270415 | Oct 2005 | JP |
2005-287599 | Oct 2005 | JP |
2006-167173 | Jun 2006 | JP |
2007-002885 | Jan 2007 | JP |
2007-043821 | Feb 2007 | JP |
2007-089972 | Apr 2007 | JP |
2007-089974 | Apr 2007 | JP |
2007-215292 | Aug 2007 | JP |
2007-247489 | Sep 2007 | JP |
2008-011611 | Jan 2008 | JP |
2008-104278 | May 2008 | JP |
2008-132131 | Jun 2008 | JP |
2008-099453 | Aug 2008 | JP |
2008-193838 | Aug 2008 | JP |
2008-297997 | Dec 2008 | JP |
2008-301634 | Dec 2008 | JP |
2006-254619 | Sep 2009 | JP |
2010-136863 | Jun 2010 | JP |
2012-021413 | Feb 2012 | JP |
1993-07388 | Apr 1993 | WO |
1996-31934 | Oct 1996 | WO |
1997-42413 | Nov 1997 | WO |
2005-028000 | Mar 2005 | WO |
2005-034312 | Apr 2005 | WO |
2009-150893 | Dec 2009 | WO |
2009-157408 | Dec 2009 | WO |
2010-067682 | Jun 2010 | WO |
2010-101082 | Sep 2010 | WO |
2011-013483 | Feb 2011 | WO |
2011-090927 | Jul 2011 | WO |
2012-047550 | Apr 2012 | WO |
2014-116639 | Jul 2014 | WO |
2014-179271 | Nov 2014 | WO |
Entry |
---|
Asama, et al., “Suspension Performance of a Two-Axis Actively Regulated Consequent-Pole Bearingless Motor,” IEEE Transactions on Energy Conversion, vol. 28, No. 4, Dec. 2013, all pages. |
Terumo Heart, Inc., “Handled With Care—Significantly Reduce the Risk of Cell Damage,” Terumo brochure, Apr. 2010, all pages. |
Yamazaki, et al., “Development of a Miniature Intraventricular Axial Flow Blood Pump,” ASAIO Journal, 1993, all pages. |
Kosaka, et al.; “Operating Point Control System for a Continuous Flow Artificial Heart: In Vitro Study”; ASAIO Journal 2003, all pages. |
Extended European Search report dated Apr. 2, 2013 in European Patent Application No. 10748702.7, all pages. |
Extended European Search report dated Nov. 19, 2012 in European Patent Application No. 10748677.1, all pages. |
International Search Report and Written Opinion dated Jul. 14, 2009 in International Patent Application No. PCT/JP2009/061318, filed Jun. 22, 2009, all pages. |
International Preliminary Report on Patentability dated Feb. 8, 2011 in International Patent Application No. PCT/JP2009/061318, filed Jun. 22, 2009, all pages. |
International Search Report and Written Opinion dated Apr. 12, 2011 in International Patent Application No. PCT/JP2011/050925, filed Feb. 24, 2011, all pages. |
International Preliminary Report on Patentability dated Sep. 18, 2012 in International Patent Application No. PCT/JP2011/050925, filed Jan. 20, 2011, all pages. |
International Search Report and Written Opinion dated Apr. 12, 2011 in International Patent Application No. PCT/JP2011/054134, filed Jun. 22, 2009, all pages. |
International Preliminary Report on Patentability dated Oct. 23, 2012 in International Patent Application No. PCT/JP2011/054134, filed Jun. 22, 2009, all pages. |
International Search Report and Written Opinion dated Sep. 13, 2011 in International Patent Application No. PCT/JP2011/064768, filed Jun. 28, 2011 all pages. |
International Preliminary Report on Patentability dated Feb. 12, 2013 in International Patent Application No. PCT/JP2011/064768, filed Jun. 28, 2011 all pages. |
Extended European Search report dated Jan. 1, 2013 in European Patent Application No. 09831788.6, all pages. |
Decision to Grant dated Aug. 27, 2020 in European Patent Application No. 14792355.1, 2 pages. |
Number | Date | Country | |
---|---|---|---|
20200009307 A1 | Jan 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15640001 | Jun 2017 | US |
Child | 16577242 | US | |
Parent | 13873551 | Apr 2013 | US |
Child | 15640001 | US |